Skip to main content
SpringerLink
Log in

Purging of Bone Marrow

  • Chapter
Book cover The HLA System in Clinical Transplantation

  • 116 Accesses

Abstract

A variety of techniques has been used for the purpose of removing normal T cells and tumor cells from bone marrow. Here, the various methods devised and the problems associated with each procedure will be briefly discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ball ED (1988) In vitro purging of bone marrow for autologous marrow transplantation in acute myelogenous leukemia using myeloid-specific monoclonal antibodies. Bone Marrow Transplant 3:387–392

    PubMed  CAS  Google Scholar 

  • Bast RC Jr, Montogomery RB, Haleem J, Kurtzberg J, Rhinehardt-Clark A, Leslie D, Boyer C, Smith C, Olsen G, Frankel A, Ring D, Ramakrishnan A, Houston L, Nadler L, Ritz L, Lebien T (1987) Bone marrow purging with antibody and complement: an American review. Bone Marrow Transplant 2: [Suppl 2] 58–65

    Google Scholar 

  • Blakey DC, Thorpe PE (1988) On overview of therapy with immunotoxins containing ricin or its A-chain. Antibody Immunoconjug Radiopharmaceut 1:1 — 16

    CAS  Google Scholar 

  • Butturini A, Gale RP (1988) T cell depletion in bone marrow transplantation for leukemia: current results and future directions. Bone Marrow Transplant 3:185–192

    PubMed  CAS  Google Scholar 

  • Champlin R, Winston H, Gajewski J, Feig S, Burnison M, Holley G, Greenbérg P, Lee K, Schmid I, Giorgi J, Yam P, Petz L, Winston D, Warner N, Reichert R (1990) Selective depletion of CD8+T lymphocytes for prevention of graft-versus host disease after allogeneic bone marrow transplantation. Blood 76:418–423

    PubMed  CAS  Google Scholar 

  • Charak BS, Brynes RK, Katsuda S, Groshen S, Chen SC, Mazumder A (1991) Induction of graft versus leukemia effect in bone marrow transplantation: dosage and time schedule dependency of interleukin-2 therapy. Cancer Research 51:2015–2020

    PubMed  CAS  Google Scholar 

  • Douay L, Gorin NC, Laporte JP, Lopez M, Najman A, Duhamel G (1984) ASTA Z 7557 (INN mafosfamide) for the in vitro treatment of human leukemic bone marrows. Invest New Drugs 2:187–190

    Article  PubMed  CAS  Google Scholar 

  • Freedman AS, Takvorian T, Anderson KC, Mauch P, Rabinowe SN, Blake K, Yeap B, Soiffer R, Coral F, Heflin L, Ritz J, Nadler LM (1990) Autologous bone marrow transplantation in B-cell non-Hodgkin’s lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse. Clin Oncol 8:784–791

    CAS  Google Scholar 

  • Gale RP, Champlin RE (1986) Bone marrow transplantation in acute leukaemia. Clin Hematol 15:851–872

    CAS  Google Scholar 

  • Gee AP, Boyle MDP (1988) Purging tumor cells from bone marrow by use of antibody and complement: a critical appraisal. JNCI 80:154–159

    PubMed  CAS  Google Scholar 

  • Goldstone AH, Singer CRJ, Gribben JG, Jarrett M (1988) Fifth report of EBMTG experience of ABMT in malignant lymphoma. Bone Marrow Transplant 3: [Suppl 2]:33–36

    Google Scholar 

  • Gorin NC, Aegerter P, Auvert B, Meloni G, Goldstone AH, Korbling M, Herve P, Burnett A, Maraninchi D, Carella A, Verdonck LF, Lowenberg R, de Planque MM, Helbig W, Reiffers J, Porcellini A, Rizzoli V, Souillet G, Alessandrino EP, Franklin IM, Goldman JM (1990) Autologous bone marrow transplantation for acute myelocytic leukemia in remission: decreased risk or relapse associated with marrow purging by mafosfamide. Blood 8: 1606–1614

    Google Scholar 

  • Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ, Ritz J, Nadler LM (1991) Immunologic purging of marrow assesses by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 22:1525–1533

    Article  Google Scholar 

  • Hertler A, Frankel AE (1989) Immunotoxins: a clinical review of their use in the treatment of malignancies. Clin Oncol 12:1932–1942

    Google Scholar 

  • Janossy G, Campana D, Amlot P (1987) Application of cytolytic monoclonal antibodies and complement in autologous bone marrow transplantation (BMT). Bone Marrow Transplant 2 [Suppl 2]:66–73

    Google Scholar 

  • Jones RJ, Vogelsang GB, Hess AD, Farmer ER, Mann RB, Geller RB, Piantadosi S, Santos GW (1989) Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet 8:754–756

    Article  Google Scholar 

  • Kemshead JT, Heath L, Gibson FM, Katz F, Richmond F, Treleaven J, Ugelstad J (1986) Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: experiences, improvements and observations. Br J Cancer 54:771–778

    Article  PubMed  CAS  Google Scholar 

  • Kernan NA, Collins NH, Cunningham I, Castro-Malaspina H, Flomenberg N, Gulati S, Brochstein J, Emanuel D, Laver J, Keever C, Bordignon C, Burns J, Frame J, Small T, Gillio A, Bonilla MA, Pecora A, Kushner B, Quijana C, Pelus L, Welte K, O’Reilly RJ (1987) Prevention of GVHD in HLA-identical marrow grafts by removal of T cells with soybean agglutinin and SRBCs. Bone Marrow Transplant 2 [Suppl 12]:13 —17

    Google Scholar 

  • Kersey J, LeBien T, Ramsay N, Filipovich A, McGlave P, Uckun F, Blazar B, Vallera D (1987) Antibodies and immunotoxins for bone marrow purging. Bone Marrow Transplant 2 [Suppl 2]:47 —52

    Google Scholar 

  • Kiesel S, Haas R, Moldenhauer G, Kvalheim G, Pezzutto A, D0rken B (1987) Removal of cells from a malignant B-cell line from bone marrow with immunomagnetic beads and with complement and immunoglobulin switch variant mediated cytolysis. Leuk Res 11:1119–1125

    Article  PubMed  CAS  Google Scholar 

  • Kvalheim G, Fodstad O, Pihl A, Nustad K, Pharo A, Ugelstad J, Funderud S (1987) Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies. Cancer Res 47:846–851

    PubMed  CAS  Google Scholar 

  • Kvalheim G, Funderud S, Kval0y S, Gaudernack G, Beiske K, Jakobsen E, Jakobsen AB, Pihl A, Fodstad O (1988 a) Successful clinical use of an anti-HLA-DR monoclonal antibody for autologous bone marrow transplantation. JNCI 80:1322–1325

    PubMed  CAS  Google Scholar 

  • Kvalheim G, S0rensen O, Fodstad O, Funderud S, Kiesel S, D0rken B, Nustad K, Jakobsen E, Ugelstad J, Pihl A (1988 b) Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use. Bone Marrow Transplant 3:31–41

    PubMed  CAS  Google Scholar 

  • Kvalheim G, Jakobsen E, Rusten L, Dorken B, Fodstad O, Beiske K, Funderud S, Herve P, Langholm R, Jetne V, Smeland E, Sandven P, Pihl A, Foss Abrahamsen A, Host H, Kvaloy S (1991) Autologous bone marrow transplantation of non-Hodgkin’s lymphomas with marrow purged with immunomagnetic beads. Proceedings of 17th Annual Meeting of EBMT, p 116

    Google Scholar 

  • Martin PJ (1987) T cell purging with antibody-Seattle experience. Bone Marrow Transplant 2 [Suppl 2]:53–57

    Google Scholar 

  • Noga S J, Donneberg AD, Santos GW (1987) The use of elutriation to purge lymphocytes from human bone marrow. Bone Marrow Transplant 2 [Suppl 2]:18–22

    Google Scholar 

  • Olsnes S, Pihl A (1982) Chimeric toxins. Pharmacol Ther 15:335–381

    Google Scholar 

  • Reisner Y, Kapoor N, O’Reilly RJ, Good RN (1980) Allogenic bone marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet 11:1320–1324

    Article  Google Scholar 

  • Reisner Y, Gan J (1985) Differential binding of soybean agglutinin to human neuroblastoma cell lines: potential application to autologous bone marrow transplantation. Cancer Res 45:4026–4031

    PubMed  CAS  Google Scholar 

  • Ritz J, Pesando JM, Notis-McConarty J, Lazaarus H, Schlossman SF (1980) A monoclonal antibody to the human acute lymphoblastic leukemia antigen. Nature 283:585–587

    Article  Google Scholar 

  • Ritz J, Sallan SE, Bast RC, Lipton JM, Clavell LA, Feeney M, Hercend T, Nathan DG, Schlossman SF (1982) Autologous bone marrow transplantation in cALLA-positive acute lymphoblastic leukaemia after in vitro treatment with J 5 monoclonal antibody and complement. Lancett 11:60–63

    Article  Google Scholar 

  • Rowley SD, Jones RJ, Piantadosi S, Braine HG, Colvin OM, Davis J, Saral R, Sharkis S, Wingard J, Yeager AM, Santos GW (1989) Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia. Blood 74:501–506

    PubMed  CAS  Google Scholar 

  • Stong RC, Uckun F, Youle RJ, Kersey JH, Vallera DA (1985) Use of multiple T cell-directed intact ricin immunotoxins for autologous bone marrow transplantation. Blood 66:627–635

    PubMed  CAS  Google Scholar 

  • Treleaven JG, Gibson FM, Ugelstad J, Rembaum A, Philip T, Caine GD, Kemshead JT (1984) Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres. Lancet 1:70–73

    Article  PubMed  CAS  Google Scholar 

  • Uhr JW (1984) Immunotoxins: harnessing nature’s poisons. J Immunol 133: I-X

    PubMed  CAS  Google Scholar 

  • Vartdal F, Kvalheim G, Lea TE, Bosnes V, Gaudernack G, Ugelstad J, Albrechtsen D (1987) Depletion of T-lymphocytes from human bone marrow. Transplantation 43:366–371

    Article  PubMed  CAS  Google Scholar 

  • Vartdal F, Albrechtsen D, Ringden O, Kvalheim G, Lea T, Bosnes V, Gaudernack G, Brinchmann J, Ugelstad J (1987) Immunomagnetic treatment of bone marrow allografts. Bone Marrow Transplant 2 [Suppl 2]:94–103

    Google Scholar 

  • Vitetta ES, Uhr JW (1985) Immunotoxins: redirecting nature’s poisons. Cell 41:653–654

    Article  PubMed  CAS  Google Scholar 

  • Yeager AM, Wiley JM, Jones R, Rowley SD, Zuehlsdorf M, Colvin OM, Santos GW (1987) Pharmacologic treatment of bone marrow to eliminate clonogenic tumor cells: laboratory and clinical studies. Bone Marrow Transplant 2 [Suppl 2]:34–42

    Google Scholar 

Download references

Authors
  1. G. Kvalheim
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department Group for Laboratory Medicine, University of Oslo Rikshospitalet, Pilestredet 32, 0027, Oslo, Norway

    Bjarte G. Solheim

  2. Department of Microbiology and Immunology, New York Medical College, 10595, Valhalla, NY, USA

    Soldano Ferrone

  3. Department for Clinical Immunology, Huddinge sjukhus, 141 86, Huddinge, Sweden

    Erna Möller

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kvalheim, G. (1993). Purging of Bone Marrow. In: Solheim, B.G., Ferrone, S., Möller, E. (eds) The HLA System in Clinical Transplantation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77506-2_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77506-2_29

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-77508-6

  • Online ISBN: 978-3-642-77506-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation